Subscribe

Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company
Refine Search
GSK: ‘Whoever moves first has UPC advantage’
Europe
GSK: ‘Whoever moves first has UPC advantage’
Value-for-money UPC is worth it says GSK corporate counsel | Court offers alternative to costly US litigation | Head of vaccine patents says UPC offers “strategic plank” in Europe.   10 October 2024
Pfizer and BioNTech win UK COVID-19 dispute
Europe
Pfizer and BioNTech win UK COVID-19 dispute
Duo successfully invalidate two CureVac patents in the UK | High Court deems patents invalid due to lack of inventive step and insufficient technical contribution | CureVac “disappointed” but stressed outcome does not affect ongoing litigation in Germany and US.   10 October 2024
Roche to outside counsel: ‘Law firms must adapt to the modern world’
Europe
Roche to outside counsel: ‘Law firms must adapt to the modern world’
Roche’s chief trademark officer has more than filing and searches on his to-do list—and external counsel must keep up, he tells Marisa Woutersen.   9 October 2024
Europe
Astellas defends blockbuster cancer treatment patent
A UK court upholds the patent for Astellas Pharma's life-extending prostate cancer treatment | Judgment dismisses attempts by Accord Healthcare, Sandoz, and Teva to invalidate the patent | Parallel litigation in Germany and Netherlands ongoing.   8 October 2024
Americas
Regeneron denied safe harbour defence in COVID-19 drug dispute
Judge says use of patented protein mNeonGreen not covered by Section 271(e)(1) provision I Allele granted summary judgment in patent infringement suit.   8 October 2024
Americas
Moderna wins reprieve in COVID-19 vaccine dispute
Alnylam backed down after judge’s patent interpretation favoured Moderna | Case is part of a spate of infringement lawsuits aimed at both Moderna and Pfizer | Plaintiff may be allowed to refile in future.   3 October 2024
Americas
Boehringer sues Indian manufacturer over diabetes drug generic
German pharma giant claims Granules India’s ANDA infringes five patents I Combination therapy Jentadueto among Boehringer’s top three products in 2023   3 October 2024
Europe
UK judge ends J&J unit’s hopes of reviving Stelara patent
Janssen Biotech denied permission to appeal invalidation of ustekinumab patent I Samsung Bioepis convinced UK court to revoke patent in July.   1 October 2024
Unified Patent Court
‘It was like starting all over again’: Tobias Wuttke
Having been involved in more than 30 cases at the UPC, the Bardehle Pagenberg litigator tells Marisa Woutersen why success at the game-changing court is a team effort.   1 October 2024
Europe
‘This is a big problem’: The CRISPR controversy and the ‘mess’ at the heart of the EPO’s appeals boards
A request by CRISPR scientists to withdraw their patents over allegations of mishandling by the EPO’s Boards of Appeals has thrust a ‘fundamentally unfair, uncertain system’ into sharp focus, finds Sarah Speight.   27 September 2024